Molecular characterization and cancer ri
โ
A. A. Tesoriero; E. M. Wong; M. A. Jenkins; J. L. Hopper; kConFab; M. A. Brown;
๐
Article
๐
2005
๐
John Wiley and Sons
๐
English
โ 243 KB
๐ 1 views
Genetic screening of women from multiple-case breast cancer families and other research-based endeavors have identified an extensive collection of germline variations of BRCA1 and BRCA2 that can be classified as deleterious and have clinical relevance. For some variants, such as those in the conserv